The Potential Use of Rosmarinus officinalis L. as Antinociceptive Agent: A Systematic Review Tropical Journal of Natural Product Research
Article Sidebar
Main Article Content
Abstract
Pain is an uncomfortable symptom following numerous diseases, which may decrease the quality of life. Many pain-relieving agents have been used throughout history, such as non-steroidal anti-inflammatory drugs (NSAIDs). Unfortunately, these medications may increase the risk of unfavourable adverse effects, such as gastrointestinal and cardiovascular problems. Lately, herbal medicine has emerged as an effective pain-relieving medication with lower side effects. Due to its diverse phytochemical compounds, Rosmarinus officinalis L. (RO), a widely known herb, has a high potential to be used as a pain-relieving agent. This review aims to provide comprehensive information regarding the applications of RO as pain-relieving agents in various pain-induction methods. This study used a systematic review approach by gathering 998 studies from 3 databases and then choosing 16 studies suitable to the inclusion criteria. The process of study selection was conducted following the PRISMA diagram. Pain-related studies that involve the use of intraperitoneal or per-oral as the route of RO extract administration were reviewed in this study. RO contains various phytochemicals, such as flavonoids, carnosic acid, and carnosol, which can potentially interfere with pain mechanisms. RO reduces the pain symptoms observed through several pain evaluation methods while decreasing the expression of pain-related biomarkers.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
1. Das V. An introduction to pain pathways and pain “targets.” In: Progress in Molecular Biology and Translational Science. Vol 131. Elsevier B.V.; 2015;131:1-30. doi:10.1016/bs.pmbts.2015.01.003
2. Nicholas M, Vlaeyen J, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, Evers S, Giamberardino M, Goebel A, Korwisi B, Perrot S, Svensson P, Wang S, Treede R. The IASP classification of chronic pain for ICD-11: Chronic primary pain. Pain. 2019;160(1):28-37.
doi:10.1097/j.pain.0000000000001390
3. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273-e283. doi:10.1016/j.bja.2019.03.023
4. Singh Sarla G. Pain and different types of painkillers. Published online 2020. www.matjournals.com
5. Farkhondeh T, Samarghandian S, Pourbagher-Shahri AM. Hypolipidemic effects of Rosmarinus officinalis L. J Cell Physiol. 2019;234(9):14680-14688. doi:10.1002/jcp.28221
6. Ahmed HM, Babakir-Mina M. Investigation of rosemary herbal extracts (Rosmarinus officinalis) and their potential effects on immunity. Phytother. Res. 2020;34(8):1829-1837. doi:10.1002/ptr.6648
7. De Oliveira JR, Camargo SEA, De Oliveira LD. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. J Biomed Sci. 2019;26(1). doi:10.1186/s12929-019-0499-8
8. Yamamoto J, Yamada K, Naemura A, Yamashita T, Arai R. Testing various herbs for antithrombotic effect. Nutrition. 2005;21(5):580-587. doi:10.1016/j.nut.2004.09.016
9. Estévez M, Ramírez R, Ventanas S, Cava R. Sage and rosemary essential oils versus BHT for the inhibition of lipid oxidative reactions in liver pâté. LWT. 2007;40(1):58-65. doi:10.1016/j.lwt.2005.07.010
10. De Melo G, Grespan RFonseca J, Farinha T, Silva E, Romero A, Bersani-Amado C, Cuman R. Rosmarinus officinalis L. essential oil inhibits in vivo and in vitro leukocyte migration. J Med Food. 2011;14(9):944-949. doi:10.1089/jmf.2010.0159
11. González-Trujano M, Peña EMartínez A, Moreno J, Guevara-Fefer P, Déciga-Campos M, López-Muñoz F. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J Ethnopharmacol. 2007;111(3):476-482. doi:10.1016/j.jep.2006.12.011
12. Bakirel T, Bakirel U, Keleş OÜ, Ülgen SG, Yardibi H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J Ethnopharmacol. 2008;116(1):64-73. doi:10.1016/j.jep.2007.10.039
13. Allegra A, Tonacci A, Pioggia G, Musolino C, Gangemi S. Anticancer activity of Rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials. Nutrients. 2020;12(6):1-25. doi:10.3390/nu12061739
14. Bozin B, Mimica-Dukic N, Samojlik I, Jovin E. Antimicrobial and antioxidant properties of Rosemary and Sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem. 2007;55(19):7879-7885. doi:10.1021/jf0715323
15. Lucarini R, Bernardes W, Ferreira D, Tozatti M, Furtado R, Bastos J, Pauletti P, Januário A, Silva M, Cunha W. In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid, and its acetyl ester derivative. Pharm Biol. 2013;51(9):1087-1090. doi:10.3109/13880209.2013.776613
16. Ai-Sereiti’ MR, Abu-Amer M, Sen P. Pharmacology of Rosemary (Rosmarinus Officinalis Linn.) and Its Therapeutic Potentials. Indian J. Exp. Biol. 1999;37:124-130
17. Hsieh CL, Peng CH, Chyau CC, Lin YC, Wang HE, Peng RY. Low-density lipoprotein, collagen, and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects. J Agric Food Chem. 2007;55(8):2884-2891. doi:10.1021/jf0631833
18. Bouhassira D. Neuropathic pain: Definition, assessment, and epidemiology. Rev Neurol (Paris). 2019;175(1-2):16-25. doi:10.1016/j.neurol.2018.09.016
19. Bohic M, Pattison L, Anissa Jhumka Z, Rossi H, Thackray J, Ricci M, Foster W, Arnold J, Mossazghi N, Yttri E, Tischfield M, St John Smith E, Abdus-Saboor I, Abraira V. Behavioral and nociceptor states of inflammatory pain across timescales in 2D and 3D. BioRxiv. 2021:2021-06. doi:10.1101/2021.06.16.448689
20. Falodun A, Okunrobo LO, Uzoamaka N. Phytochemical screening and anti-inflammatory evaluation of methanolic and aqueous extracts of Euphorbia heterophylla Linn (Euphorbiaceae). Afr J Biotechnol. 2006;5(6):529. http://www.academicjournals.org/AJB
21. Mannelli L, Micheli L, Maresca M, Cravotto G, Bellumori M, Innocenti M, Mulinacci N, Ghelardini C., Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors. Sci Rep. 2016;6. doi:10.1038/srep34832
22. Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10. doi:10.3389/fnmol.2017.00284
23. Gawade SP. Acetic acid-induced painful endogenous infliction in writhing test on mice. J Pharmacol Pharmacother. 2012;3(4):348. doi:10.4103/0976-500X.103699
24. Ghasemzadeh Rahbardar M, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed. Pharmacother. 2017;86:441-449. doi:10.1016/j.biopha.2016.12.049
25. Martínez AL, González-Trujano ME, Chávez M, Pellicer F. Antinociceptive effectiveness of triterpenes from rosemary in visceral nociception. J Ethnopharmacol. 2012;142(1):28-34. doi:10.1016/j.jep.2012.03.052
26. Abdelhalim A, Karim N, Chebib M, Aburjai T, Khan, Johnston A, Hanrahan J. Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis. J Pharm Pharm Sci. 2015;18(4):448-459. www.cspsCanada.org
27. Motta PG, Perez AC, Alves DP, Duarte IDG. Peripheral control of inflammatory but not neuropathic pain by endogenous cholinergic system. Pharmacol. 2011;88(1-2):18-25. doi:10.1159/000328409
28. Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease: Involvement of antioxidative enzymes induction. Chem Biol Interact. 2015;225:40-46. doi:10.1016/j.cbi.2014.11.011
29. Jin K, Qian C, Lin J, Liu B. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. Front Oncol. 2023;13. doi:10.3389/fonc.2023.1099811
30. Ren K, Torres R. Role of interleukin-1β during pain and inflammation. Brain Res Rev. 2009;60(1):57-64. doi:10.1016/j.brainresrev.2008.12.020
31. Mirza FJ, Zahid S, Holsinger RMD. Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action. Molecules. 2023;28(5). doi:10.3390/molecules28052306
32. Bifulco G, Maione F, Cantone V, Pace S, Chini M, Bisio A, Romussi G, Pieretti S, Werz O, Koeberle A, Mascolo N. Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions. Br J Pharmacol. 2017;174:1497-1508. doi:10.1111/bph.v174.11/issuetoc
33. Ghasemzadeh MR, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol. 2016;194:117-130. doi:10.1016/j.jep.2016.08.043
34. Zendehdel M, Beizaee S, Taati M, Bashiri A. Antinociceptive Mechanisms of Rosmarinus Officinalis Extract in Mice Using Writhing Test. Int. J. Vet. Sci. Res. 2011; 5(4):240-246
35. Borges R, Lima E, Keita H, Ferreira I, Fernandes C, Cruz R, Duarte J, Velázquez-Moyado J, Ortiz B, Castro A, Ferreira J, da Silva Hage-Melim L, Carvalho J. Anti-inflammatory and antialgic actions of a nanoemulsion of Rosmarinus officinalis L. essential oil and a molecular docking study of its major chemical constituents. Inflammopharmacology. 2018;26(1):183-195. doi:10.1007/s10787-017-0374-8
36. Abdelhalim A, Karim N, Chebib M, Aburjai T, Khan, Johnston A, Hanrahan J. Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis. J. Pharm. Pharm. Sci. 2015;18(4):448-59.
37. Ferreira Perazzo F, Carlos Tavares Carvalho J, Romana Dipe de Faria L, Silva Lima C, Carlos Tavares Carvalho J. Anti-Inflammatory and Antinociceptive Activities of the Essential Oil from Rosmarinus Officinalis L. Int J Pharm Sci Rev Res. 2011;7(2):1-8.
38. Vahdat SM, Khavarpour M, Kazemi S. Chemical Composition, Antimicrobial and Analgesic Properties of Rosmarinus Officinalis L. from North of Iran. J. Med. Plants By-Prod. 2020;9(Special):107-114.
39. Martínez AL, Eva González-Trujano M, Pellicer F, López-Muñoz FJ, Navarrete A. Antinociceptive Effect and GC/MS Analysis of Rosmarinus Officinalis L. Essential Oil from Its Aerial Parts. Planta medica. 2009;75(05):508-511.
40. Martínez AL, González-Trujano ME, Chávez M, Pellicer F. Antinociceptive effectiveness of triterpenes from rosemary in visceral nociception. J Ethnopharmacol. 2012;142(1):28-34. doi:10.1016/j.jep.2012.03.052
41. Laura Martínez A, Eva González-Trujano M, López-Muñoz FJ. Endogenous Opioids Participation in the Effect of Rosmarinus Officinalis L. in the Visceral, Inflammatory, and Gout Arthritis Nociception in Rodents. Salud mental. 2013;36(2):141-147.
42. Emami F, Ali-Beig H, Farahbakhsh S, Mojabi N, Rastegar-Moghadam B, Arbabian S, Kazemi M. Hydroalchoholic Extract of Rosemary (Rosmarinus Officinalis L.) and its Constituent Carnosol Inhibit Formalin-induced Pain and inflammation in Mice. Pak. J. Biol. Sci. 2013;16(7):309-316.
43. Rasoulian B, Hajializadeh Z, Esmaeili-Mahani S, Rashidipour M, Fatemi I, Kaeidi A. Neuroprotective and antinociceptive effects of rosemary (Rosmarinus officinalis L.) extract in rats with painful diabetic neuropathy. J. Physiol. Sci. 2019;69(1):57-64. doi:10.1007/s12576-018-0620-x
44. Rahbardar MG, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Rosmarinic acid attenuates development and existing pain in a rat model of neuropathic pain: An evidence of anti-oxidative and anti-inflammatory effects. Phytomedicine. 2018;40:59-67. doi:10.1016/j.phymed.2018.01.001